Production (Stage)
cbdMD, Inc.
YCBD
$0.8579
-$0.0011-0.13%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.12% | 12.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.12% | 12.23% | |||
| Cost of Revenue | 4.51% | -18.53% | |||
| Gross Profit | -12.97% | 38.59% | |||
| SG&A Expenses | 4.89% | -0.35% | |||
| Depreciation & Amortization | -4.06% | 3.54% | |||
| Other Operating Expenses | -56.72% | 171.37% | |||
| Total Operating Expenses | 0.68% | 6.71% | |||
| Operating Income | -462.92% | 72.74% | |||
| Income Before Tax | -3,284.11% | 109.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3,284.11% | 109.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3,284.11% | 109.88% | |||
| EBIT | -462.92% | 72.74% | |||
| EBITDA | -194.43% | 835.07% | |||
| EPS Basic | -9.88% | -23.01% | |||
| Normalized Basic EPS | -367.03% | 65.68% | |||
| EPS Diluted | -9.88% | -21.91% | |||
| Normalized Diluted EPS | -367.03% | 65.68% | |||
| Average Basic Shares Outstanding | 36.80% | -30.66% | |||
| Average Diluted Shares Outstanding | 36.80% | -30.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||